Drug intelligence / Profile preview

sodium nucleinate

Development stage
Phase 3
Modality
Small Molecules
Administration
Oral
01

Overview

Sodium nucleinate is a small molecule, chemically identified as 2-amino-1,2,3,4-tetrahydrophthalazine-1,4-dione sodium salt dihydrate, and is a derivative of luminol. It is registered in the Russian Federation as Tamerit. The drug exhibits immunomodulatory and anti-inflammatory properties. Its mechanism of action involves inhibiting the oxidative burst in human monocytes and polymorphonuclear cells, and suppressing the production of pro-inflammatory cytokines such as TNF-alpha, IFN-gamma, and IL-6. It also stimulates T-cellular immunity, enhances specific immunity, restores phagocytic function, and possesses membranoprotective properties, along with the ability to enhance intracellular metabolism. It has been investigated for various conditions, including metastatic colorectal cancer, diabetic retinopathy, and infectious diseases.

Brand names
Tamerit
Other names
SN2-amino-1,2,3,4-tetrahydrophthalazine-1,4-dione sodium salt dihydrate
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)IFNG (Interferon gamma)NOX (NADPH oxidase)

Beyond the preview

Go deeper on sodium nucleinate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium nucleinate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call